A 31-page amicus brief backed by CAA, Madonna, and Anne Hathaway argues the creative industries already have the infrastructure to license AI training data, undercutting OpenAI's core defense.

SpaceX will keep half its compute for internal AI projects and rent the rest at spot rates, betting the super-intelligence shortage will last.

If the claim holds up, personalized phage therapy could become a new frontline weapon against antibiotic resistance - but proof is far from final.

The consulting giant's strategic review of its Greater China unit could set a benchmark for every multinational weighing its China exposure.

The SPCX listing breaks records, but Japanese household investors quietly took a meaningful chunk of the biggest payday ever.